Stabilized thrombin
US11229688B2 · kind B2 · utility
0Cited by
14References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 22, 2018 |
| Grant date | Jan 25, 2022 |
| Priority date | — |
| Expiry date | Jan 19, 2039 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/974
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to compounds, methods for stabilizing thrombin activity with a thrombin binding oligonucleotide and to stabilized thrombin. The thrombin binding oligonucleotide is capable of inhibiting thrombin activity whereby the inhibition can be reversed with an antisense oligonucleotide.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.